Evaluation of a novel electrochemical detection method for Chlamydia trachomatis: Application for point-of-care diagnostics

David M. Pearce, Daniel P. Shenton, Jeffrey Holden, Charlotte A. Gaydos

Research output: Contribution to journalArticle

Abstract

Atlas Genetics has developed a point-of-care device for Chlamydia trachomatis utilizing a novel electrochemical detection principle. The assay has a time-to-result of less than 25 min. An independent preclinical validation study using 306 pretyped clinical samples determined a clinical sensitivity of 98.1% and specificity of 98.0%.

Original languageEnglish (US)
Pages (from-to)755-758
Number of pages4
JournalIEEE Transactions on Biomedical Engineering
Volume58
Issue number3 PART 2
DOIs
StatePublished - Mar 1 2011

Keywords

  • Chlamydia
  • electrochemistry
  • infectious disease
  • point-of-care

ASJC Scopus subject areas

  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Evaluation of a novel electrochemical detection method for Chlamydia trachomatis: Application for point-of-care diagnostics'. Together they form a unique fingerprint.

  • Cite this